|
Article Excerpt
CARLSBAD, Calif. -- CancerVax Corporation (NASDAQ:CNVX) today announced that it has filed with the Securities and Exchange Commission a shelf registration statement on Form S-3 which, when declared effective, will permit CancerVax, from time to time, to offer and sell up to $80 million of common stock.
CancerVax plans to use the proceeds from subsequent offerings to continue the clinical development of its lead specific active immunotherapeutic (SAI) product candidate, Canvaxin(TM), to initiate clinical trials of SAI-EGF, its lead SAI product candidate that targets the EGFR signaling pathway, to further the preclinical development of its other product candidates, including its anti-angiogenic antibodies and peptides, and product candidates based on its T-oligonucleotide technology, and to fund other working...
|
|
More articles from Business Wire
PPG Bestows Company's Highest R&D Honor on Three Individuals., November 08, 2004
InSight Health Services Holdings Corp. to Host First Quarter Fiscal 20..., November 08, 2004
Callon Petroleum Company Issues Guidance for Fourth Quarter 2004., November 08, 2004
SPACEHAB Files Tort Claim for Losses on Space Shuttle Mission., November 08, 2004
Medical Board of California Poised to Implement New Enforcement Progra..., November 08, 2004
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
